Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer

By Incrocci L.   Hop W.C.J.   Slob A.K.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 116-120

Elsevier

Access to resources Recommend Favorite

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

By Porst H.   Padma-Nathan H.   Giuliano F.   Anglin G.   Varanese L.   Rosen R.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 121-125

Elsevier

Access to resources Recommend Favorite

The efficacy of sildenafil in different etiologies of erectile dysfunction

By Başar Murat   Tekdoğan Ümit   Yılmaz Erdal   Başar Halil   Atan Ali   Batislam Ertan  

International Urology and Nephrology, Vol. 32, Iss. 3, 2001-09 ,pp. : 403-407

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy, safety, and use of sildenafil in urologic practice

By Fagelman E.   Fagelman A.   Shabsigh R.  

Urology, Vol. 57, Iss. 6, 2001-06 ,pp. : 1141-1144

Elsevier

Access to resources Recommend Favorite

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate - an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

By Zelefsky M.J.   Mckee A.B.   Lee H.   Leibel S.A.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 775-778

Elsevier

Access to resources Recommend Favorite